Certa Therapeutics Strengthens Asia-Pacific Leadership with Acquisition of Melbourne-Based OccuRx to Advance GPR68-Driven Fibrotic Disease Therapies biopharmaapac.com/news/31/56… via @BiopharmaApac
6
148
congratulations @DrEmmaLJohnston
Chancellor, Jane Hansen AO, today announced the appointment of @DrEmmaLJohnston as 21st Vice-Chancellor of @unimelb. Prof. Emma Johnston is the first woman to be appointed Vice-Chancellor of the University and will commence in Feb 2025. #WomenInScience unimelb.edu.au/newsroom/news…
2
121
Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011) biospace.com/press-releases/…
5
179
The European Medicines Agency granted orphan drug status to FT011, Certa Therapeutics’ oral treatment candidate for systemic sclerosis (SSc). sclerodermanews.com/news/orp…
4
157
one of the best air displays ever. great USA AU collaboration that started in California
Ummm GC did someone leave the gate to the Raptor pen open? 👀
TWO #USAF F-22's are flocking this way!
#PacificAirshow #GoldCoast
🇦🇺 The F-22's are sure to command your attention and get that jaw droppin' low! 16-18 August. 🤩✈️
🎟️ pacificairshow.com
1
156
Prof Chris Denton presenting our phase 2a Data on skin transcriptomics #EULAR24 #certatherapeutics
Super funds, CSL pour $270m into venture capital fund afr.com/technology/super-fun…
Certa Therapeutics’ FT011 granted US FDA fast track for systemic sclerosis biotechdispatch.com.au/news/…
















